These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8231377)

  • 1. [2,3-dimercaptosuccinic acid: a new chelating agent, safe and efficacious, for lead poisoning].
    Nogué S; Sanz-Gallén P; Munné P; To-Figueras J
    Med Clin (Barc); 1993 Oct; 101(12):478-9. PubMed ID: 8231377
    [No Abstract]   [Full Text] [Related]  

  • 2. [Occupational lead poisoning treated with dimercaptosuccinic acid (DMSA) ( letter)].
    Sanz-Gallén P; Nogué S; Munné P; To J
    Rev Clin Esp; 1992 Jun; 191(1):58-9. PubMed ID: 1321469
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of chronic occupational lead poisoning with dimercaptosuccinic acid (DMSA)].
    Grandjean P; Jacobsen IA; Jørgensen PJ; Lings S; Andersen O
    Ugeskr Laeger; 1991 Oct; 153(41):2897-9. PubMed ID: 1659012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chelation therapy to treat lead toxicity in children.
    Wegmann K
    Minn Med; 1992 Nov; 75(11):25-7. PubMed ID: 1331737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
    Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chelation therapy in children exposed to lead.
    Shannon M; Woolf A; Binns H
    N Engl J Med; 2001 Oct; 345(16):1212-3. PubMed ID: 11642245
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic lead poisoning treated with dimercaptosuccinic acid.
    Grandjean P; Jacobsen IA; Jørgensen PJ
    Pharmacol Toxicol; 1991 Apr; 68(4):266-9. PubMed ID: 1650943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
    van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
    Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prevention of childhood lead poisoning--the only solution.
    Rosen JF; Mushak P
    N Engl J Med; 2001 May; 344(19):1470-1. PubMed ID: 11346814
    [No Abstract]   [Full Text] [Related]  

  • 10. Rash and pyrexia after succimer (dimercaptosuccinic acid; DMSA).
    Varma A; Bradberry SM; Vale JA
    Clin Toxicol (Phila); 2017 Aug; 55(7):680. PubMed ID: 28349748
    [No Abstract]   [Full Text] [Related]  

  • 11. Lead poisoning from a retained bullet: a case report and review.
    Khurana V; Bradley TP
    J Assoc Acad Minor Phys; 1999; 10(2):48-9. PubMed ID: 10826009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacodynamic characteristics of dithiol compounds and D-penicillamine in microsaturnism].
    Lubianova IP
    Vrach Delo; 1979 Nov; (11):103-7. PubMed ID: 230640
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
    Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
    Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytosis secondary to chronic lead poisoning.
    Al Momen A
    Platelets; 2010; 21(4):297-9. PubMed ID: 20196630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mobilization of lead in patients with chronic poisoning by that metal. Oral penicillamine].
    González-Ramírez D; Zuñiga-Charles M; Narro-Juárez A
    Arch Invest Med (Mex); 1990; 21(3):279-83. PubMed ID: 2131778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Succimer, an oral lead chelator.
    Mann KV; Travers JD
    Clin Pharm; 1991 Dec; 10(12):914-22. PubMed ID: 1663439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc supplementation of chelation therapy in saturnism. Preliminary study.
    Bădulici S; Chirilă M
    Rom J Intern Med; 1992; 30(3):211-5. PubMed ID: 1475600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ambulatory treatment for lead poisoning].
    Otermin Maia I; Belzunce Elizalde M
    An Med Interna; 2002 Aug; 19(8):440-1. PubMed ID: 12244800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.